A Multi-Center, Randomized, Double-Blind, Phase III Trial to Evaluate the Safety and Efficacy of Saxagliptin Co-administered With Dapagliflozin Compared to Saxagliptin or Dapagliflozin All Given as add-on Therapy to Metformin in Subject With Type 2 Diabetes

Clinical trial NCT02681094 · COMPLETED

Trial details

NCT number

NCT02681094

Sponsor

AstraZeneca

Status

COMPLETED

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2016-02-26

Primary completion

2017-07-15

Enrollment

905

View on ClinicalTrials.gov